Latest Breaking News On - Trisalus life sciences inc - Page 7 : comparemela.com

TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update

Completed merger with MedTech Acquisition Corporation and started public trading August 11th Reported 3Q23 revenues of $5.2 million in 3Q23, up 32% over prior year and nine-month year to date net.

Steven-katz
Jodi-devlin
Mary-szela
Trisalus-life-sciences-inc
Twitter
Linkedin
Trisalus-life-sciences
Nasdaq
Society-for-immunotherapy-of-cancer
Exchange-commission
Infusion-system
Pressure-enabled-drug-delivery

Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications

04.11.2023 - TriSalus Life Sciences Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today presented additional Phase 1 clinical data . Seite 1

Texas
United-states
Sapna-patel
Stevenc-katz
Trisalus-life-sciences-inc
University-of-texas-md-anderson-cancer-center
Society-of-immunotherapy
Nasdaq
Trinav-infusion-system
Progression-free-survival
Disease-control-rate
Chief-medical-officer

Intrahepatic Cholangiocarcinoma Market to Grow Rapidly During the Study Period (2019-2032), Examines DelveInsight | Key Players - Virogin Biotech, Syndax, Delcath Systems, AstraZeneca, Amgen, Jazz, BeiGene

/PRNewswire/ DelveInsight s Intrahepatic Cholangiocarcinoma Market Insights report includes a comprehensive understanding of current treatment practices,.

Spain
Beijing
China
France
United-kingdom
United-states
Japan
Germany
Italy
Intrahepatic-cholangiocarcinomatherapies
Prnewswire-delveinsight
Genoscience-pharma

DelveInsight Business Research, LLP: Intrahepatic Cholangiocarcinoma Market to Grow Rapidly During the Study Period (2019-2032), Examines DelveInsight | Key Players - Virogin Biotech, Syndax, Delcath Systems, AstraZeneca, Amgen, Jazz, BeiGene

DelveInsight Business Research, LLP: Intrahepatic Cholangiocarcinoma Market to Grow Rapidly During the Study Period (2019-2032), Examines DelveInsight | Key Players - Virogin Biotech, Syndax, Delcath Systems, AstraZeneca, Amgen, Jazz, BeiGene
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan
Germany
Italy
Spain
Beijing
China
France
Steigen
Baden-wüberg
United-kingdom
United-states
Kinnate-biopharma

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Amprius Technologies (NYSE:AMPX), ARM Holdings (NASDAQ:ARM)

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

United-states
India
Raymond-james
Redburn-atlantic
Solowin-holdings
Semtech-corporation
Paulv-walsh-jr
Conduent-incorporated
Connexa-sports-technologies-inc
Perspective-therapeutics-inc
Prokidney-corp
Amprius-technologies-inc